Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

PHSYX vs. PRHSX: which is better?

Bottom line

PHSYX vs PRHSX: the short answer

PHSYX (Putnam Global Health Care Fund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) share a meaningful slice of their top holdings — about 62% by weight.

But PRHSX is far broader, holding 279 positions to 115 for PHSYX, so beyond the top names it adds exposure PHSYX doesn't have.

PHSYX is cheaper at 0.79% vs 0.83% — a difference of $4.00 a year per $10,000 invested.

Over five years, PHSYX returned +8.1% a year vs +4.2% for PRHSX (reporting dates differ).

Updated Nov 19, 2026

PHSYX vs PRHSX side by side

PHSYXPRHSX
TypeMutual fundMutual fund
Fund familyFranklin TempletonT. Rowe Price
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.79%0.83%
Annual cost per $10k$79$83
10-yr cost on $10k (prospectus)$978$1,025
Max front load0%—
12b-1 fee0%—
1-yr return+1.5%+17.7%
5-yr return (annualized)+8.1%+4.2%
10-yr return (annualized)+7.8%+9.1%
Best quarter—+23.5%
Worst quarter—−15.8%
Net assets (fund)$1.5B$11.9B
Number of holdings115279
Portfolio turnover67%62%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Holdings overlap

13 of PHSYX's top 25 holdings also appear in PRHSX's top 25.

Shared top holdings
HoldingPHSYXPRHSX
Eli Lilly & Co.13.15%14.28%
Johnson & Johnson8.46%6.63%
UnitedHealth Group, Inc.6.93%5.99%
AbbVie, Inc.6.05%5.10%
Merck & Co., Inc.4.88%4.01%
Thermo Fisher Scientific, Inc.4.50%2.52%
Intuitive Surgical, Inc.4.04%1.87%
CVS Health Corp.2.74%0.94%
Gilead Sciences, Inc.2.63%2.82%
Cardinal Health, Inc.2.12%1.03%
Vertex Pharmaceuticals, Inc.1.97%2.28%
Bristol-Myers Squibb Co.1.75%2.11%
Amgen, Inc.1.11%1.82%

Source: SEC Form N-PORT

PHSYX top 10

  1. Eli Lilly & Co. — 13.15%
  2. Johnson & Johnson — 8.46%
  3. UnitedHealth Group, Inc. — 6.93%
  4. AbbVie, Inc. — 6.05%
  5. Novartis AG — 5.13%
  6. Merck & Co., Inc. — 4.88%
  7. AstraZeneca plc — 4.67%
  8. Thermo Fisher Scientific, Inc. — 4.50%
  9. Intuitive Surgical, Inc. — 4.04%
  10. Sanofi SA — 3.23%

PRHSX top 10

  1. Eli Lilly & Co — 14.28%
  2. Johnson & Johnson — 6.63%
  3. Unitedhealth Group Inc — 5.99%
  4. Abbvie Inc — 5.10%
  5. Merck & Co. Inc. — 4.01%
  6. Gilead Sciences Inc — 2.82%
  7. Thermo Fisher Scientific Inc — 2.52%
  8. Vertex Pharmaceuticals Inc — 2.28%
  9. Bristol-myers Squibb Co — 2.11%
  10. Abbott Laboratories — 1.89%

FAQ

What is the difference between PHSYX and PRHSX?
PHSYX (Putnam Global Health Care Fund) and PRHSX (T. Rowe Price Health Sciences Fund, Inc.) share a meaningful slice of their top holdings — about 62% by weight. But PRHSX is far broader, holding 279 positions to 115 for PHSYX, so beyond the top names it adds exposure PHSYX doesn't have.
Which is cheaper, PHSYX or PRHSX?
PHSYX has the lower expense ratio (0.79%).
Should I own both PHSYX and PRHSX?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.